Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2017-03-10 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20170310 - Acquisition of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document details transactions where UCB SA/NV sold options and purchased UCB shares, explicitly mentioning these actions are in the context of share delivery obligations under Long Term Incentive Programs. It provides specific dates, prices, and the resulting total shareholding (3.36% of total shares issued). This activity—the company acquiring its own shares—falls directly under the definition of 'Transaction in Own Shares' (share repurchase/issuance). Although it results in a change in major shareholding, the primary action described is the transaction itself, making 'POS' the most accurate classification over 'MRQ' (which is for notification of changes by *other* significant shareholders crossing thresholds, although a transparency notification was filed). The document is a direct report of the company's own share transaction activity.
2017-03-10 English
20170310 - Acquisition d'actions propres final.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres" (Acquisition of own shares) and details transactions where UCB SA bought back a total of 880,000 shares on various dates in March 2017, both over-the-counter and via the Euronext Brussels order book. This activity directly corresponds to the definition of a company buying back or selling its own shares. This matches Filing Type Code POS (Transaction in Own Shares). Although it mentions a transparency declaration crossing the 3% threshold, the primary subject is the share repurchase program itself.
2017-03-10 French
20170310 - Inkoop van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled 'Inkoop van eigen aandelen' (Purchase of own shares) and details multiple transactions where UCB NV bought back its own shares on Euronext Brussels and OTC between March 1st and March 10th, 2017. It explicitly mentions that as a result of these purchases, UCB NV crossed the 3% threshold of voting rights and that a transparency declaration was submitted to the FSMA. This activity directly corresponds to the definition of a company reporting on transactions involving its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). Although it mentions a transparency declaration being submitted, the core content is the detailed record of share repurchases, making POS a more specific fit than RNS or RPA.
2017-03-10 Dutch
20170309 - Transparency notification Capital GC final (002).pdf
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'transparency notification' received pursuant to Article 14 of the law regarding the 'disclosure of large shareholdings'. It details a change in shareholding percentage (crossing downward the 10% threshold) by The Capital Group Companies, Inc. This content directly corresponds to regulatory filings concerning changes in significant share ownership, which maps to the Major Shareholding Notification (MRQ) category. The document is a formal disclosure of this event, not just an announcement of a report.
2017-03-09 English
20170309 - Notification de transparence Capital GC final.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Déclaration de transparence" (Transparency Declaration) and explicitly references compliance with Article 14 of the Belgian law of May 2, 2007, regarding the disclosure of significant shareholdings. It details a change in ownership percentage (crossing the 10% threshold downwards) by The Capital Group Companies Inc. This type of mandatory disclosure concerning changes in major share ownership thresholds is specifically covered by the 'Major Shareholding Notification' category. Although the document is a formal regulatory disclosure, it is not a general regulatory filing (RNS) or a report itself (like 10-K or IR). It directly reports on insider/major shareholder transactions, fitting the definition of MRQ (Major Shareholding Notification).
2017-03-09 French
20170309 - Transparantieverklaring Capital GC final.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Transparantieverklaring" (Transparency Declaration) and explicitly states it is based on Article 14 of the law regarding the disclosure of major shareholdings ('openbaarmaking van belangrijke deelnemingen'). It details a reduction in the shareholding of 'The Capital Group Companies Inc.' below the 10% threshold, specifying the exact number of shares and the date of the transaction (March 2, 2017). This content directly corresponds to notifications about changes in significant share ownership levels, which aligns perfectly with the definition for Major Shareholding Notification (MRQ).
2017-03-09 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.